4//SEC Filing
LIDGARD GRAHAM PETER 4
Accession 0001209191-21-012164
CIK 0001124140other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:31 PM ET
Size
11.0 KB
Accession
0001209191-21-012164
Insider Transaction Report
Form 4
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-02-17$142.66/sh−2,131$304,008→ 35,596 total - Exercise/Conversion
Restricted Stock Units
2021-02-16−3,972→ 11,916 total→ Common Stock (3,972 underlying) - Exercise/Conversion
Common Stock
2021-02-16+3,972→ 37,727 total
Holdings
- 4,673(indirect: By Trust)
Common Stock
- 12,725(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 16, 2021.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 52,994 shares, Mr. Lidgard also holds, in the aggregate, an additional 119,019 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]Represents a restricted stock unit award that partially vested on February 16, 2021. The restricted stock units vest in four equal annual installments beginning on February 16, 2021.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001216274
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:31 PM ET
- Size
- 11.0 KB